Study Design of a Phase 2 Ublituximab Dose-Confirmation Study in Children and Adolescents with Relapsing Multiple Sclerosis: ULTIMATE KIDS I

Drug Category : Array
Conference Category : Array
Lead Author : Mok K, et al.
Published Date : 05/02/2026
Download Link : /wp-content/uploads/2026/02/TGTX-ACTRIMS-2026-KIDS-I-Mok.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top